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Kazutoshi Kasho3,4, Susana Guerra1, Sjoerd Wanrooij 3,*, Juan Méndez 2,* and
Luis Blanco 1,*
1Centro de Biologı́a Molecular Severo Ochoa, CSIC-UAM, 28049, Madrid, Spain, 2Spanish National Cancer
Research Centre (CNIO), 28029, Madrid, Spain, 3Department of Medical Biochemistry and Biophysics, Umeå
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ABSTRACT
PrimPol is the second primase in human cells, the
first with the ability to start DNA chains with dNTPs.
PrimPol contributes to DNA damage tolerance by
restarting DNA synthesis beyond stalling lesions,
acting as a TLS primase. Multiple alignment of eu-
karyotic PrimPols allowed us to identify a highly con-
served motif, WxxY near the invariant motif A, which
contains two active site metal ligands in all members
of the archeo-eukaryotic primase (AEP) superfamily.
In vivo and in vitro analysis of single variants of the
WFYY motif of human PrimPol demonstrated that the
invariant Trp87 and Tyr90 residues are essential for
both primase and polymerase activities, mainly due
to their crucial role in binding incoming nucleotides.
Accordingly, the human variant F88L, altering the
WFYY motif, displayed reduced binding of incoming
nucleotides, affecting its primase/polymerase activi-
ties especially during TLS reactions on UV-damaged
DNA. Conversely, the Y89D mutation initially asso-
ciated with High Myopia did not affect the ability
to rescue stalled replication forks in human cells.
Collectively, our data suggest that the WFYY motif
has a fundamental role in stabilizing the incoming 3′-
nucleotide, an essential requisite for both its primase
and TLS abilities during replication fork restart.
INTRODUCTION
The DNA replication machinery is responsible for the in-
tegrity and stability of genetic information, making use of
several DNA polymerases to replicate the genome, but also
to repair and tolerate lesions. Replicases are assisted by spe-
cialized enzymes called primases, which make short RNA
strands serving as ‘primers’ (1). Human cells have two DNA
primases: Prim1 that operates at nuclear DNA and is a het-
erodimer (p48 + p58) wherein p48 is the catalytic subunit.
A complex of this primase with Pol is responsible for ini-
tiating synthesis of the leading strand at each origin, and
for recurrent priming of Okazaki fragments at the lagging
strand during DNA replication (2).
The second human primase is PrimPol, an enzyme with
combined DNA primase and TLS polymerase activities
that is involved in nuclear and mitochondrial replication.
Cells lacking PrimPol are viable, but fail to maintain normal
nuclear fork progression rate even in the absence of DNA
damage (3) and display impaired mitochondrial DNA repli-
cation (4,5). PrimPols have been described in plasmids (6),
bacteria (7), archea (8) and eukaryotes (4). While Prim-
Pols belong to the same Archeal-Eukaryotic Primase (AEP)
super-family as conventional primases, they combine both
DNA primase and DNA polymerase activities in a single
polypeptide and a single active site (4,9). Human Prim-
Pol contains the active-site motifs A, B and C, shared
by members of the AEP superfamily, and a specific Zn-
finger domain similar to that of herpesvirus UL52 pri-
mase (10), which specifically interacts with the initiating
5′ nucleotide (11,12). In vivo studies demonstrated that
PrimPol assists DNA replication by repriming stalled forks
ahead of lesions or obstacles, leaving behind an unrepli-
cated gap to be repaired post-replicatively (3,13,14). This
repriming activity also facilitates replication traverse of
DNA interstrand crosslinks (15). In addition, PrimPol ef-
ficiently bypasses certain DNA lesions such as 8-oxo-7,8-
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dihydrodeoxyguanosine (8-oxo-dG) by directly incorporat-
ing either dNTPs or NTPs opposite the lesion (4,16–18).
DNA lesions like pyrimidine dimers (6-4PP, CPD) or AP
sites can also be bypassed by PrimPol by reannealing the
primer ahead of the lesion (16). The in vivo relevance of this
TLS potential is currently unknown.
In this study, we identified the conserved motif WxxY
at the N-terminus of eukaryotic PrimPols, in proximity to
the active site motif A conserved in the whole AEP super-
family. The flanking amino acids of this motif (Trp87 and
Tyr90 in human PrimPol) are the most invariant in ani-
mal and plant PrimPols. By site-directed mutagenesis and
a combination of in vitro and in vivo analysis, we show that
these two invariant residues are irrelevant for ssDNA bind-
ing, but essential to form the pre-ternary complex Prim-
Pol:ssDNA:dNTP (11), an intermediate which precedes the
primase action required to rescue stalled replication forks.
By extrapolation to the 3D-structure of human PrimPol in
complex with DNA and deoxynucleotide (19), which re-
flects its polymerase mode, we propose that the WxxY mo-
tif plays an indirect role in stabilizing the 3′-incoming nu-
cleotide in both TLS primase and polymerase activities. Ac-
cordingly, both activities were lost when Trp87 and Tyr90
were mutated to glycine and aspartate, respectively. Interest-
ingly, a non-conservative mutation at Phe88 (F88L) showed
a marked reduction in the affinity for the incoming 3′-
nucleotide that preferentially affected the primase and TLS
reactions on UV-damaged DNA. Conversely, the Y89D
variant, which was previously claimed to be associated with
High Myopia (20,21), and more recently with Progressive
External Ophtalmoplegia (PEO; 22), had only a minor ef-
fect on the PrimPol catalytic activities. Our data is therefore
consistent with extensive genetic analysis that indicated that
Y89D PrimPol variant occurs randomly in the population
and is not overrepresented in patients with High Myopia
(23).
MATERIALS AND METHODS
Oligonucleotides, nucleotides and enzymes
Conventional DNA oligonucleotides were synthesized by
Sigma Aldrich (St Louis, MO, USA). Oligonucleotides used
in the in vitro DNA polymerization assays were purified
by 8 M urea-20% polyacrylamide gel electrophoresis and
5′-labeled with [ -32P]ATP (3000Ci/ mmol) from Perkin-
Elmer (Waltham, MA, USA) and T4 polynucleotide kinase
(New England Biolabs, Ipswich, MA, USA) for 45 min at
37◦C. Hybridizations were performed in 50 mM Tris–HCl
pH 7.5 and 0.3 M NaCl for 10 min at 80◦C and cooled down
to room temperature. Unlabeled ultrapure dNTPs were sup-
plied by GE Healthcare (Chicago, IL, USA). [ -32P]ATP,
[-32P]dGTP and [-32P]dTTP were obtained from Perkin
Elmer. Human Pol holoenzyme (subunits A + B) was
kindly provided by M. Falkenberg’s lab (Gothenburg Uni-
versity, Sweden). Human full length PolDIP2 (amino acid
1-368, c-terminally His6 tagged) was cloned into pET21d
plasmid, introduced into E. coli ArcticExpress (DE3) cells,
and purified by Ni-NTA beads and HiTrap Heparin column
(GE Healthcare).
Construction of PrimPol mutants
For in vitro analysis, desired point mutations were intro-
duced in the expression plasmid pET16::PrimPol following
the ‘quick-change’ site-directed mutagenesis protocol from
Stratagene. Human wild-type (WT) PrimPol and the mu-
tated variants (W87G, F88L, Y89D, Y90D) were expressed
in Escherichia coli BL21 (DE3) pRIL and purified as previ-
ously described (4). To further support the data, the Y89D
mutant was expressed and purified by following a different
procedure, as previously described (24). For in vivo analysis,
DNA sequences encoding WT PrimPol, or PrimPol vari-
ants AxA (3), W87G, F88L, Y89D and Y90D were cloned
into Gateway expression vectors introducing an N-terminal
V5 tag (Invitrogen, Carlsbad, CA, USA). Transient trans-
fections were performed using Lipofectamine 2000 (Invit-
rogen).
Primary sequence alignment and 3D-visualization
Multiple alignments of the indicated amino acid se-
quence were performed using the MULTALIN server
(25; http://multalin.toulouse.inra.fr/multalin/). Three-
dimensional images were created with Swiss-PdbViewer
(DeepView) program, developed within the Swish Institute
of Bioinformatics (SIB) at the Structural Bioinformatics
Group at the Biozentrum in Basel, and using human
PrimPol PDB ID: 5L2X, which corresponds to the crystal
structure of human PrimPol ternary complex (19).
DNA primase assays
DNA primase activity of PrimPol WT and the mutants of
the WFYY motif were evaluated using a 29-mer oligonu-
cleotide (3′-T15GTCCT10-5′) as template, which contains a
putative herpesvirus priming initiation site (GTCC) (4,26).
The reaction mixture (20 l) contained buffer R (50 mM
Tris pH 7.5, 5% Gly, 75 mM NaCl, 1 mM MnCl2, 1 mM
DTT and 0.1 g/l BSA), PrimPol WT or mutated variants
of WFYY (200 nM), [ -32P]ATP (16 nM; 3000 Ci/mmol)
and increasing concentrations of dGTP (1, 10 and 100 M).
The reaction was incubated during 30 min at 30◦C. Reac-
tions were stopped by addition of formamide loading buffer
(10 mM EDTA, 95% v/v formamide and 0.3% w/v xylene-
cyanol) and loaded in 8 M urea-containing 20% polyacry-
lamide sequencing gels. Radiolabeled bands corresponding
to nascent primers were detected by autoradiography, and
used to quantify the primase activity by densitometry of
the autoradiographs. Quantitation of the primase activity.
When indicated, an oligonucleotide with the GTCA core
sequence (3′-T15GTCAT10-5′) was used as a template in the
presence of [-32P]dGTP (16 nM; 3,000 Ci/mmol) and ATP
(100 M), or ATP + dTTP (100 M), as indicated. The re-
action mixture (20 l) contained buffer R and PrimPol WT
or mutated variants (200 nM) were incubated during 30 min
at 30◦C. Reactions were stopped and analyzed as described
above.
To measure processivity during primase synthesis, a dif-
ferent template was used (3′T29GTCAGACAGCAT20 5′),
in the presence of [ -32P]ATP (16 nM; 3,000 Ci/mmol),
dGTP + dCTP + dTTP (100 M each), WT PrimPol or
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to 400 nM), and the incubation was carried out for various
times (5, 20, 40 and 60 min) at 30◦C.
The primase capacity of the WFYY mutants (100 nM)
was evaluated in combination with the mitochondrial DNA
polymerase gamma (Pol ; 20 nM), using M13 ssDNA (5
ng/l) as template. Incubations were performed in reac-
tion buffer (50 mM Tris–HCl pH 7.5, 1 mM DTT, 0.1
mg/ml BSA) in the presence of 16 nM [-32P]dGTP, 100
M (dATP, dCTP and dTTP), 100 M GTP and 100 M
MnCl2 + 4 mM MgCl2 as metal cofactors. After incubation
for 30 min at 37◦C, the reactions were stopped by adding 50
l TE and loaded into a G50 + 0.1% SDS to remove free la-
beled nucleotide. The eluted products were dried and resus-
pended in 20 l H2O. Reactions were run in a 0.8% agarose
native gel, dried and exposed for autoradiography. The po-
sition of the M13 ssDNA template used (circular and linear
form) was determined by ethidium bromide staining of the
agarose gel.
EMSA for binary complex and pre-ternary complex
Enzyme:ssDNA binding was performed in buffer A [50
mM Tris–HCl pH 7.5, 40 mM NaCl, 2.5% (w/v) glycerol,
2.5% (w/v) PEG-4000, 1 mM DTT, 0.1 mg/ml BSA], using
5′ PNK-[ -32P]-labeled 3′T20GTCCT365′ oligonucleotide (1
nM) and increasing concentrations of either WT PrimPol
or W87G, F88L, Y89D, Y90D mutants (10, 20, 40, 80 nM)
in the absence of metal. The reaction (in 20 l) was incu-
bated at 30◦C for 10 min. Subsequently, loading buffer (30%
glycerol, 1 mM EDTA, 0.1% xylene cyanol and 0.1% bro-
mophenol blue) was added and the reaction was analyzed
in a native 6% polyacrylamide gel run at 150 V for 120 min
at 4◦C in Tris-glycine pH 8.3 buffer. After electrophoresis,
the gel was dried and the mobility shift of free ssDNA vs en-
zyme:ssDNA complex was analyzed by autoradiography.
Pre-ternary complex formation of WT PrimPol or
W87G, F88L, Y89D, Y90D mutants (1 M) and labeled
nucleotide [-32P]dGTP or [-32P]dTTP (16 nM) was eval-
uated in buffer B [50 mM Tris pH 7.5, 2.5% (w/v) glyc-
erol, 40 mM NaCl, 1 mM MnCl2, 1 mM DTT and 0.1
g/l BSA], supplemented when indicated with ssDNA
3′T20GTCCT365′ (0.5 M; 60-mer), MnCl2 (1 mM). Reac-
tions (20 l final volume) were incubated for 10 min at 30◦C.
Then loading buffer was added and the reactions were ana-
lyzed as described above.
DNA polymerase and 8oxoG translesion synthesis assays
For ‘standing start’ analysis of polymerase activity, a 5′
PNK-[ -32P]-labeled 15-mer oligonucleotide primer (5′-
GATCACAGTGAGTAC-3′) was hybridized to a 28-mer
oligonucleotide template (5′-AGAAGTGTATCT(X)GT
ACTCACTGTGATC-3′; X stands for G or 8oxoG) and
used to evaluate WT PrimPol and the mutated variants
(200 nM) in polymerase activity and translesion synthesis
in the presence of increasing dNTPs concentrations (1, 10,
100 M). The reactions (20 l) in buffer R were incubated
at 30◦C during 60 min, then stopped and analyzed as de-
scribed above.
To analyze the fidelity of the active PrimPol variants
the insertion of each nucleotide dATP, dCTP, dGTP or
dTTP independently at 1 M opposite the undamaged G
and 8oxoG site, was measured. Reactions were incubated
at 30◦C during 30 min, then stopped and analyzed as de-
scribed above.
Steady-state kinetics analysis of nucleotide incorporation
Kinetic parameters were obtained by measuring the for-
mation of a +1 primer-extended product by either wild-
type PrimPol or by the WFYY mutants F88L and Y89D.
Assays contained a 5′ 32P-labeled primer (5′-GATCAC
AGTGAGTAC-3′) hybridized to a partially complemen-
tary template (5′-AGAAGTGTATCTCGTACTCACTG
TGATC-3′; C in bold is the first base to be copied). Reac-
tions were carried out (in 20 l) using Buffer R (50 mM
Tris pH 7.5, 5% Glycerol, 75 mM NaCl, 1 mM MnCl2, 1
mM DTT and 0.1 g/l BSA), 250 nM primer/template,
40 nM purified WT PrimPol (F88L or Y89D) and increas-
ing concentrations of the first complementary nucleotide,
dGTP (from 0.25 to 40 M). After 10 min incubation at
30◦C, reactions were stopped and the products resolved
as previously described. +1 primer-extended products were
detected using a BAS reader 1500 (Fujifilm). Autoradio-
graphs were quantified by densitometry using ImageJ soft-
ware. The observed rate of nucleotide incorporation (+1 ex-
tended primer) was plotted as a function of nucleotide con-
centration. Data were fit to the Michaelis–Menten equa-
tion using non-linear regression to determine the apparent
Km and kcat parameters.
DNA polymerase and 6-4PP translesion synthesis assays
A 5′ PNK-[ -32P]-labeled 16-mer oligonucleotide primer
(5′-CACTGACTGTATGATG-3′) for ‘standing start’ 6-
4PP TLS experiments was hybridized to either control (un-
damaged) 30-mer oligonucleotide template (5′-CTCGTC
AGCATC(TT)CATCATACAGTCAGTG-3′), or to dam-
aged templates containing an 6-4PP thymine dimer site
(6,4), kindly provided by S. Iwai (Osaka University, Japan).
The reaction mixture (20 l) contained buffer R, 1 mM
MnCl2, 2.5 nM [ -32P]-labeled primer/template structure,
dNTPs (100 M) and purified human PrimPol or the
WFYY motif variants (200 nM). After incubation for 30
min at 30◦C, primer extension products were analyzed as
described above.
DNA primase/polymerase assays of Y89D in the presence of
Mg2+
As shown in Supplementary Figure S3, the Y89D mu-
tant and the corresponding WT PrimPol (purified from
a different source) were tested in different polymeriza-
tion assays, and in the presence of activating Mg2+ ion.
A 5′-TET fluorophore-labeled 25-mer oligonucleotide
primer (5′- ATAGGGGTATGCCTACTTCCAACTC-3′)
was hybridized to 70-mer oligonucleotide template (5′-
GAGGGGTATGTGATGGGAGGGCTAGGATATGA
GGTGAGTTGAGTGGAGTTGGAAGTAGGCATAC
CCCTAT-3′) (27). The reaction mixture (10 l) contained
10 mM Bis-Tris propane (pH 7.0), 10 mM MgCl2, 1 mM
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mutant purified as described (24), and PolDIP2 when
indicated. After 10 min incubation at 37◦C, reactions were
stopped by addition of formamide loading buffer (0.5%
SDS, 25 mM EDTA, 95% v/v formamide and xylene-
cyanol). Products were separated by 7 M urea–containing
10% polyacrylamide sequencing gels, and analyzed by
using Typhoon 9400 (Amersham Bioscience) scanner.
The capacity of Y89D to functionally interact with Pol
was tested using M13mp18 ssDNA (New England Bio-
labs, Ipswich, MA, USA) as a template, as described previ-
ously (5,28). The reaction mixtures contained 10 mM Bis-
Tris propane (pH 7.0), 10 mM MgCl2, 1 mM DDT, 1 mM
ATP and 200 M dNTPs including [-32P]dCTP. When in-
dicated 200 nM WT or Y89D PrimPol, purified as described
(24), 20 nM PolA, 30 nM PolB (as a dimer), and 200 nM
PolDIP2 were added. The reaction was performed using 5
nM of primed or non-primed (the 28-mer primer is comple-
mentary to M13mp18 nucleotides 6,218–6,245) M13mp18
ssDNA, and after 60 min at 37◦C the reactions were stopped
with 0.5% SDS/25 mM EDTA, and purified with G-25
columns (GE Healthcare). Products were separated by al-
kaline (30 mM NaOH, 1 mM EDTA)–1% agarose gel, and
analyzed with a Typhoon 9400 scanner.
Circular dichroism (CD) spectroscopy
CD analyses of PrimPol WT and the four WFYY mu-
tants, purified as described (24), were performed on a
JASCO J-810 spectropolarimeter (JASCO, Easton, MD,
USA) equipped with a Peltier temperature control unit that
maintained the temperature at 10◦C. A 1 mm quartz cuvette
(Hellma, Müllheim, Germany) was used. Before measure-
ments, protein samples were buffer exchanged into a buffer
containing 15 mM Tris–HCl (pH 7.5) and 400 mM NaF,
and the protein concentrations were adjusted to 0.1 mg/ml.
The measurements were made in 5 replicates and averaged
in the instrument software. The mean residue ellipticity was
calculated using the protein molar concentration and the
number of peptide bonds.
Single-molecule analysis of DNA replication in stretched
fibers
Stable HeLa-shPrimPol cells were generated by infection of
HeLa cells, obtained from the Spanish National Cancer Re-
search Center Repository, with a lentiviral vector carrying
a doxycycline (dox)-inducible shRNAmir targeting the se-
quence 5′ CCTGATGTCTGTGAGATTT 3′ in the 3′ UTR
of PRIMPOL gene. Expression of PRIMPOL shRNAmir
and downregulation of endogenous PrimPol protein was in-
duced by adding 1 g/ml dox to the culture medium for
3 days. For functional complementation assays, V5-tagged
PrimPol protein (either WT or the indicated mutant deriva-
tive) was reintroduced in HeLa-shPrimPol cells by tran-
sient transfection of pcDNA3.1/nV5-PrimPol plasmids us-
ing Lipofectamine 2000 (Invitrogen), as described (3). To
evaluate fork rate (FR), cells were pulse-labeled with 50
M CldU (20 min) followed by 250 M IdU (20 min).
To evaluate fork restart, cells were pulse-labeled with CldU
(red) for 20 min, and irradiated with UV light (30J/m2)
for 30 min before pulse-labeling with IdU (green) for 20
min in fresh medium as described (3). Alternatively, 5 mM
HU was added to the medium for 6 h between pulses. La-
beled cells were harvested and resuspended in 0.2 M Tris
pH 7.4, 50 mM EDTA and 0.5% SDS. DNA fiber spreads
were prepared as described (3). For immunodetection of la-
beled tracks, fibers were incubated with primary antibodies
(1 h / RT) and the corresponding secondary antibodies (30
min/ RT) in a humidity chamber. In these settings, forks ar-
rested by UV irradiation or dNTP attrition (HU-treatment)
should have incorporated only the first analog, whereas
those that continued DNA synthesis should be labeled with
both analogs. DNA was stained with anti-ssDNA to assess
fiber integrity. Fiber images were obtained in a DM6000 B
Leica microscope with an HCX PL APO 40× and 0.75 NA
objective. The conversion factor used was 1 m = 2.59 kb.
In each assay, >300 tracks were measured for FR estima-
tion and >500 tracks were measured to estimate percentage
of fork restart.
Statistical methods
In column graphs, data are expressed as mean ± s.e.m.
(standard error of the mean). Statistical analyses were done
with two-tailed Student’s t-test. When the data are pre-
sented in scatter dot plots, the bar corresponds to the
median value. For the analyses of FR in stretched DNA
fibers, the data distribution is normally not Gaussian, and
differences between samples were assessed with the non-
parametric Mann–Whitney rank-sum test. Statistical anal-
ysis was performed in Prism v4.0 (GraphPad Software).
RESULTS AND DISCUSSION
WxxY motif is highly conserved in eukaryotic PrimPols
Amino acid sequence alignment of evolutionarily distant
eukaryotic PrimPols from animals and plants allowed the
identification of a short amino acid motif, WxxY (Figure 1
and Supplementary Figure S1), in the vicinity of motif A
which is universally conserved in all members of the AEP
superfamily and contains two metal ligands of the active
site (Asp114 and Glu116 in human PrimPol (4,18), and close
to the residue involved in sugar discrimination (Tyr100, 29;
green dot in Figure 1 and Supplementary Figure S1). WxxY
motif can be more precisely defined as WFYY in verte-
brates, and WxRY in plants (where x is frequently a posi-
tively charged residue). Thus, collectively, metazoans have
a WxxY motif in which the tryptophan (W) is strictly in-
variant, and the flanking tyrosine is highly conserved (Sup-
plementary Figure S1). Other members of the AEP super-
family, such as putative PrimPols from fungi (Spu), archaea
(PfuP41, pRN1, Mhu, Sis) and bacteria (Tth, Taq, Mru,
Msi1 and BcMCM), and NHEJ polymerases (MtPolDom),
do not have a conserved WxxY motif, but most of them con-
serve the tryptophan, or an equivalent aromatic residue, as
the only vestige of this motif (Figure 1).
To understand the role of this conserved motif, we per-
formed site-directed mutagenesis of Trp87, Phe88, Tyr89 and
Tyr90 amino acids of human PrimPol. The changes were
designed following different criteria. The most invariant
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Figure 1. HsPrimPol residue Trp87, embedded in motif WxxY, is conserved among different AEP enzymes. (Top) Schematics of human PrimPol showing
the position of conserved active site motifs A, B and C, shared by members of the AEP superfamily, a Zn-finger domain similar to that of herpesvirus UL52
primase and the bipartite RPA binding domain (RBD), located at the most C-terminal region. The WFYY motif described in this work (represented as a
magenta bar), is proximal to active site motif A. The colored bars inside motifs A and C indicates specific carboxylate residues acting as metal ligands (red),
and the specific histidine (purple) involved in nucleotide binding at motif B; blue bars inside the Zn finger domain indicates the cysteines and histidine that
coordinate the Zn2+ atom. (Bottom) Amino acid sequence alignment of an N-terminal segment of different AEP enzymes (spanning from the eukaryotic
PrimPol motif WxxY to the universally conserved motif A of AEPs), including Homo sapiens PrimPol (HsPrimPol), Mycobacterium tuberculosis LigD poly-
merase domain (PolDom), Pyrococcus furiosus primase catalytic subunit (Pfu-p41), plasmid pRN1 ORF904 from Sulfolubus islandicus (pRN1), and other
known or putative PrimPol enzymes in Fungi (Spicellomyces punctatus (Sp)), Archea (Methanospirillum hungatei (Mhu); Sulfolobus islandicus (Sis)) and
Bacteria (Thermus thermophilus (Tth); Thermus aquaticus (Taq); Meiothermus ruber (Mru); Meiothermus silvanus (Msi); PrimPol-helicase from Bacillus
cereus (BcMCM)). Some selected human PrimPol residues are indicated: Tyr100 (sugar discriminator; green dot); Asp112 and Glu114, (acting as metal
ligands in motif A; red asterisks); Trp87 (as part of the WFYY; magenta asterisk). The secondary structure elements, obtained from their corresponding
3D-structures (HsPrimPol, PolDom, Pfu-p41 and pRN1), are indicated with cylinders (alfa-helices) and arrows (beta strands) above the corresponding
amino acid sequence.
glycine (W87G) to abolish the aromatic ring and its poten-
tial function. Phe88, invariant in PrimPols from vertebrates
as part of their WFYY motif, was changed to leucine, mim-
icking a human PrimPol variant (F88L). Tyr89, invariant in
PrimPols from vertebrates as part of their WFYY motif,
was changed to aspartate to further study a mutant (Y89D)
that has been controversially associated with High Myopia
(20,21,23) and PEO (22). Finally, the highly conserved Tyr90
was changed to aspartate (Y90D), mimicking the natural
mutation in Tyr89, which eliminates its volume and aro-
maticity but introducing a negatively charged residue.
Trp87 and Tyr90 residues of human PrimPol are essential for
its DNA primase activity
To evaluate the possible effects of the point mutations
introduced at the WFYY motif on the function of hu-
man PrimPol, we performed a highly-specific primase in
vitro assay, which measures de novo formation of short
primer products at a single priming site (4). In this assay,
a single-stranded DNA oligonucleotide containing a pre-
ferred priming site (‘GTCC’) flanked by poly T residues
(Figure 2A) was used as a template in the presence of [ -
32P]ATP as the 5′-nucleotide, increasing concentrations of
dGTP as the incoming 3′-nucleotide, and activating Mn2+
ions. Under these conditions, WT PrimPol gave rise to the
expected products 3pAdG, 3pAdGdG, together with longer
products (3pAdGdGdG, 3pAdGdGdGdG,. . . .) due to reit-
erative dG addition via slippage (Figure 2A, lanes 2-4). In-
terestingly, the changes made at the two invariant residues
of the motif (W87G, Y90D) virtually eliminated the pri-
mase activity (Figure 2A, lanes 5–7 and 14–16), demonstrat-
ing that Trp87 and Tyr90 in human PrimPol’s WFFY motif
are essential for dimer synthesis. The histogram at Figure
2A, showing the quantification of the primase activity at 100
M dGTP, indicates that variant F88L retains only 25% of
the WT activity. The effect is even more pronounced when
using 10 M dGTP (compare lanes 3 and 9; 20% residual
activity) or 1 M dGTP (compare lanes 2 and 8; 5% activ-
ity remaining). Note that the F88L mutant required about
100-fold higher concentration of dGTP than WT PrimPol
to produce a similar pattern of initiation products (com-
pare lanes 2 and 10). Conversely, the primase activity of
the Y89D variant was only slightly reduced (60-65% of WT
PrimPol), and was not affected by the dGTP concentration
used (Figure 2A, lanes 11–13).
The effect of these mutations on the primase activity
was further analyzed by using a slightly modified oligonu-
cleotide as template (now having a ‘GTCA’ priming site) to
dissect the dimer formation step that is rate-limiting dur-
ing primer synthesis, and its further elongation to synthe-
size a longer primer (Figure 2B). Dinucleotide formation
was evaluated by providing a high concentration (100 M)
of ATP, which is valid as 5′-site nucleotide, but a very low
concentration (16 nM) of labeled [-32P]dGTP as the 3′-site
nucleotide. Progression from initiation to elongation was
assayed by providing 100 M dTTP, which allows trinu-
cleotide formation (3pAdGdT) and subsequently elonga-
tion via ATP incorporation. As expected from the previ-
ous assay, both W87G and Y90D mutants were unable
to form the initial dinucleotide also in these conditions;
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Figure 2. Trp87 and Tyr90 human PrimPol residues are required for its primase activity. (A) Primase assay using an ori-containing oligonucleotide (GTCC;
1 M) as template, WT or mutant HsPrimPol (400 nM), MnCl2 (1 mM), labeled [ -32P]ATP (16 nM) as the 5′-site nucleotide, and dGTP (1, 10, 100 M)
as the 3′-site nucleotide. The autoradiogram shows the expected A*G and A*GG, and other extension products generated by reiterative insertion of dGTP
(4). Relative quantitation of primer synthesis at 100 M dGTP, carried out by optical densitometry and normalized to 100% WT, is shown at the right. In
all cases, the histograms represent the mean ± SEM (standard error of the mean) from three different experiments. Data significance were analyzed using
Student’s t test (ns, not significant > 0.05, **P < 0.01). (B) Primase assay using a slightly modified template (GTCA; 1 M); in this case, providing ATP (100
M) and [-32P]dGTP (16 nM), and dTTP (100 M) when indicated. As in part A the reactions were analyzed by 8M urea /PAGE and autoradiography, as
described in Materials and Methods. Under these conditions, dimer (A*G), trimer (A*GT), and further elongated products (A*GTAn) could be observed.
Arrowheads indicate non-specific bands that are observed even in the absence of PrimPol (lanes 1 in parts A and B). (C) Assay to measure processivity
during primer synthesis, using a template with the preferred priming site (3′GTC) followed by an heterologous sequence (3′T29GTCAGACAGCAT20 5′),
in the presence of 16 nM [ -32P]ATP and dGTP, dCTP and dTTP, each at 100 M each. Under these conditions, long primers are formed either with
WT PrimPol or mutants F88L and Y89D, at any time point and enzyme concentration. (D) Synergy between human PrimPol and mitochondrial Pol .
The primase capacity of WFYY mutants (100 nM) was evaluated in combination with mitochondrial Pol (20 nM), and using M13 ssDNA (5 ng/l) as
template. After incubation for 30 min at 37◦C as indicated in Materials and Methods, the reactions were analyzed by native agarose gel electrophoresis and
autoradiography. The selected images are representative of at least 3 different experiments. Ethidium bromide staining of the M13 template used shows
the mobility of a prominent upper band (circular form), and that of a weak lower band (linear form). The schematics at the right indicate the origin of
different labeled products: the upper product is obtained when PrimPol makes primers on the circular DNA, which can be further extended by Pol ; the
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(Figure 2B, lanes 4–5 and 10–11). Also, in congruence with
the previous assay, mutant Y89D was able to catalyze exten-
sive elongation of the dimers at a slightly higher efficiency
(130%) than the WT PrimPol (Figure 2B; compare lanes 3
and 9). On the other hand, the F88L variant displayed a re-
duced efficiency (19% of WT activity) to form the elongated
primers (Figure 2B, compare lanes 3 and 7).
At this point we could not rule out that the effect of
the mutations introduced could be template-specific. Thus,
we used a ssDNA template with a preferred initiation site
(3′GTC) followed by an heterologous sequence which pre-
cedes a polyT tail (Figure 2C). PrimPol is allowed to start
DNA synthesis with [ -32P]ATP (16 nM) and dGTP (100
M), forming a 3pAG dimer, which can be elongated up
to 3pAGTCTGTCGT in the presence of dTTP, dCTP, and
dGTP (100 M each). Primer synthesis by WT versus F88L
and Y89D mutants was compared as a function of time (5-
60 min). This experiment showed that Y89D priming ef-
ficiency was only slightly affected (58–64%), at any reac-
tion time (Figure 2C, compare lanes 2–5 versus 14–17). On
the other hand, the reduced efficiency of F88L mutant in
primer synthesis was more evident at lower reaction times
(Figure 2C, compare lanes 2–5 versus 8–11; i.e. 10% at 20
min (lane 9) versus 21% at 60 min (lane 11). Interestingly,
this experiment shows that WT Primpol makes products
of similar size at any time point (Figure 2C, lanes 2–5),
and also at different enzyme:DNA ratios (Figure 2C, lanes
5–7), which supports our previous finding that PrimPol is
processive when making primers (11), unlike the distribu-
tive behavior observed when assayed as a polymerase on
conventional primer/template substrates. PrimPol’s proces-
sivity when priming is unaffected by mutations F88L and
Y89D (Figure 2C, lanes 8–13 and lanes 14–19, respectively).
Finally, we compared the overall capacity of WT Prim-
Pol and the WFYY mutants to generate primers in a
large heteropolymeric template sequence (M13 ssDNA),
and whether they can be efficiently extended by DNA poly-
merase gamma (Pol ), the mitochondrial replicase (30,31).
In this template context, PrimPol primase activity is evalu-
ated as an average of different events occurring at preferred
and non-preferred initiation sites. Importantly, the analysis
of the reaction is carried out by agarose gel electrophore-
sis under native separation conditions, thus preserving the
association of the nascent and labeled products with the in-
tact circular template (M13ssDNA). As shown in Figure 2D
(lane 2), a lower/faster migrating band running at the posi-
tion of linear (nicked) M13 ssDNA (stained with EtBr) was
observed when only providing Pol (in the absence of a pri-
mase), suggesting that labeling is due to the extension of the
linearized 3′-end, acting as primer after hybridization to a
(partially) complementary DNA sequence (see schematic at
the right). The upper band corresponds to the mobility of
circular ssDNA M13, and therefore, any labeling is the con-
sequence of de novo priming by PrimPol, followed by pro-
cessive elongation by Pol . As shown in Figure 2D, only
WT PrimPol (lane 3) and mutant Y89D (lane 6) were able
to make DNA primers, as judged by their efficient extension
by Pol and quantification of the upper band (Figure 2D).
Again, F88L displayed low primer synthesis ability (lane 5),
with only 27% of the WT activity. In agreement with previ-
ous data, W87G and Y90D mutants were unable to produce
DNA primers (lanes 4 and 7, respectively), thus preventing
any extension reaction by Pol .
In conclusion, the defects shown in primase activity cor-
relate well with the conservation of each individual residue
in the WFYY motif, outlining that the invariant residues
Trp87 and Tyr90 of human PrimPol are essential to initiate
dinucleotide formation during primer synthesis.
Trp87 and Tyr90 residues are crucial to form a stable pre-
ternary complex
To further investigate why these conserved residues are es-
sential for the primase activity, we studied their importance
in ssDNA binding. Electrophoretic mobility shift assays
(EMSA), carried out at different enzyme:ssDNA ratios,
demonstrated that each mutant at the WFYY motif was
able to produce a binary complex with ssDNA (E:DNA)
with the same electrophoretic mobility as WT PrimPol, and
also with similar efficiency (Figure 3A). The capacity of
WFYY mutants to form the binary complex and their sim-
ilar mobility also argues against a significant change in the
overall structure of PrimPol that could be caused by the mu-
tations. To confirm this, CD-spectra for all the mutants were
obtained, confirming the absence of significant structural
alterations (Figure 3B). Consequently, as the WFYY mo-
tif of human PrimPol is irrelevant for binding to ssDNA,
the conserved residues Trp87 and Tyr90, and to a lower ex-
tent Phe88, should be required in a later step of the priming
reaction (revised in 12).
As described before, PrimPol recognizes the G in the
‘GTCC’ core sequence as a cryptic nucleotide and forms the
initial dimer (3pAdG) in front of T and C (4): the 3′site nu-
cleotide (dGTP) is the one that binds first, forming the so-
called ‘pre-ternary complex’ PrimPol:ssDNA:dGTP in the
presence of Mn2+ ions; the second nucleotide (deoxi or ribo
ATP) gets bound at the 5′ position once the 3′ site is occu-
pied (11,12). We evaluated the formation of the E:DNA:dG
preternary complex by WFYY mutants and found that
F88L (Figure 3C, lane 6) and Y89D (Figure 3C, lane 8)
variants could form the pre-ternary complex albeit less effi-
ciently (F88L, 40% and Y89D, 60%) than WT PrimPol (Fig-
ure 3C, lane 2). Conversely, W87G and Y90D mutants were
completely unable to bind the incoming nucleotide at the
3′-site required to form the preternary complex (Figure 3B,
lanes 4 and 10, respectively), thus explaining their inactivity
in the primase assays.
Base insertion fidelity operates during formation of the
pre-ternary complex, as the bound 3′-site nucleotide is pref-
erentially complementary to the templating base (11), im-
plying its stabilization via Watson & Crick base pairing.
Pre-ternary complex formation was also tested in the pres-
ence of an incorrect 3′-site nucleotide (dTTP) to investigate
whether the impaired function of mutants F88L and Y89D
could be due to an altered orientation of the templating
base that could be beneficial for a non-complementary nu-
cleotide. However, WT PrimPol as well as the partially ac-
tive variants F88L and Y89D formed only small amounts
of pre-ternary complex with dTTP as a non-complementary
nucleotide (Figure 3C, light grey bars in the histogram).
The estimated ratio of correct vs incorrect pre-ternary com-
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Figure 3. The WFYY motif of human PrimPol is required to stabilize the preternary complex. (A) Binary complex detected by electrophoretic mobility
shift assay (EMSA) using oligonucleotide GTCC (2.5 nM) (60-mer; [ -32P]-labeled), and increasing concentrations of WT PrimPol or mutant variants (5,
10, 20, 40 nM). The retarded band detected by autoradiography (upper panel) corresponds to the E:ssDNA binary complex. The lower panel shows the
quantification (average of three different experiments) of the E:ssDNA complex by optical densitometry, expressed as percentage of the labeled ssDNA.
(B) Circular dichroism (CD) spectra of PrimPol WT and WFYY mutants, purified as described (24). CD analyses were performed on a JASCO J-810
spectropolarimeter (JASCO, Easton, MD, USA), as described in more detail in Materials and Methods. The mean residue ellipticity was calculated using
the protein molar concentration and the number of peptide bonds. The graph shows that the overall structure of W87G, F88L, Y89D and Y90D mutants
is preserved. (C) Pre-ternary complex detected by EMSA, using [-32P]dGTP (16 nM) and PrimPol WFYY variants (1 M) with 3′T36GTCCT205′ (500
nM) as ssDNA template in the presence of Mn2+ (1 mM). The histogram represents the quantification of the preternary complex (E:ssDNA:dNTP)
formed, carried out by optical densitometry (normalized to 100% WT) of the preternary complex with the complementary (dGTP; dark gray bars) or
non-complementary (dTTP; light gray bars) nucleotide. In all cases, the histograms represent the mean ± SEM (standard error of the mean) from three
different experiments. Statistical data analysis for the correct preternary complex (E:ssDNA:dG) was carried out using Student’s t test (*P < 0.05 and
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F88L (>11.7), Y89D (>10.9), suggesting that these muta-
tions do not alter the fidelity of nucleotide selection to form
the pre-ternary complex, but its efficiency.
Trp87 and Tyr90 residues are essential for PrimPol DNA poly-
merase activity
When the WFYY mutants were tested in conven-
tional DNA polymerase assays, using a pre-formed
template/primer hybrid and different concentrations of
dNTPs, the results mirrored those shown for primase activ-
ity (Figure 4A, left panel). Thus, W87G and Y90D mutants
were inactive, F88L activity was significantly reduced, and
Y89D had a near to wild-type like activity. Besides, the
latter two mutants did not show a significant alteration in
the fidelity of nucleotide incorporation, evaluated here by
comparing the preferred nucleotide for the + 1-insertion
reaction opposite dG (Figure 4B, left panels).
The reduced or null ability of some of the WFYY mu-
tants to form the pre-ternary complex (as shown in Fig-
ure 3C) suggests that the parallel defects observed in DNA
polymerization are also due to a lower affinity for the in-
coming 3′-site dNTP, that compromises the formation of
the ternary complex required for each polymerization cy-
cle. To test this idea, we determined the steady-state kinetic
parameters of the active variants F88L and Y89D during a
single nucleotide incorporation polymerization, which can
reveal differences that might not be apparent in the primer
extension assay. The reduction in the catalytic efficiency of
variants F88L (7,5-fold lower than WT) and Y89D (4,3-fold
lower than WT) was mainly due to a reduction in the affinity
for the incoming dNTP in the case of F88L (4.5-fold higher
Km than WT; 1.5-fold lower kcat than WT), but mainly due
to a reduction in kcat in the case of Y89D (1.5-fold higher
Km than WT; 3-fold lower kcat than WT; Table 1).
Besides catalyzing conventional DNA-directed DNA
synthesis, PrimPol bypasses 8oxoG lesions during polymer-
ization with high efficiency, inserting dATP slightly better
than dCTP when Mn2+ is used as metal activator (4,17,18).
As shown in Figure 4B (right panels), when the template
contained an 8-oxo-G lesion, the WFYY mutants activity
mirrored the previous results obtained with the undamaged
template: mutants W87G and Y90D mutants were inactive,
whereas F88L and Y89D had reduced polymerization activ-
ity but still elongated the primer across the damaged base as
efficiently as they did with the undamaged template (com-
pare Figure 4A, left and right panels). Similar to WT Prim-
Pol, F88L and Y89D variants inserted the correct (dCTP)
and pre-mutagenic (dATP) nucleotides at similar ratios op-
posite 8oxoG, whereas dGTP and dTTP were incorporated
at a much lower extent (Figure 4B, middle and bottom
panels).
Therefore, these data support the importance of the in-
variant residues of the WxxY motif (Trp87 and Tyr90 in
human PrimPol) in nucleotide binding also during poly-
merase reactions on either undamaged or damaged DNA
templates. On the other hand, the F88L and Y89D vari-
ants do not influence the TLS ability of PrimPol, keeping
the WT-like dC/dA insertion ratio when copying an 8oxoG
lesion.
The F88L variant is defective in alternative TLS reactions on
UV-damaged DNA
PrimPol bypasses UV lesions in the DNA template by
also using alternative TLS mechanisms based on template
distortions and primer realignment (3,16). We assessed
the TLS activity of WFYY mutants on 6,4 pyrimidine-
pyrimidone (6,4PP), a characteristic lesion caused by UV
irradiation. As expected, the W87G and Y90D mutants
were inactive, both on the undamaged (control) or dam-
aged template structures (Figure 5A and B). On the other
hand, mutant Y89D behaved essentially as the WT Prim-
Pol: (i) reaching full-length extension of the primer (+14)
when using the control undamaged template/primer struc-
ture (Figure 5A); (ii) producing a main shorter product (+8)
when the template contains the 6,4PP lesion, which requires
microhomology-based realignment of the primer ahead of
the lesion (3), as indicated in the schematic (Figure 5B).
F88L variant copied the undamaged control template less
efficiently than WT PrimPol (Figure 5A), which only par-
tially explains the strong reduction of the +8-product gen-
erated on the 6,4PP-containing template (Figure 5B). This
suggests that the F88L variant defect, which reduces its
polymerization capacity, is especially deleterious when TLS
requires the realignment of the primer beyond the lesion.
It could be possible that a deficient formation of the
ternary complex during each polymerization cycle would be
rate-limiting under conditions requiring template or primer
dislocation. A plausible explanation is that this ‘pseudo-
TLS’ reaction probably requires the formation of a stable
pre-ternary complex beyond the lesion, to trigger primer re-
alignment as a second step. The Y89D variant did not have
a significant defect to perform this ‘pseudo-TLS’ reaction,
in agreement with its competence to bind the incoming 3′-
site nucleotide. Conversely, the very low activity of the F88L
variant is compatible with its poor capacity to form a stable
pre-ternary complex (Figure 3B and C).
Mutations at motif WFYY of human PrimPol impair repli-
cation fork restart
At the time of the initial characterization of human Prim-
Pol in 2013, it was described that PrimPol downregulation
slows down fork progression, suggesting that it plays a basal
role during unperturbed DNA replication (3,13). Moreover,
PrimPol is actively recruited to rescue DNA synthesis at
stalled replication forks challenged by UV irradiation, hy-
droxyurea (HU; 3,5), or other kind of replication road-
blocks (14,32). PrimPol-dependent fork stalling could be
rescued by reintroducing wt-PrimPol in the cells, but not the
catalytically-dead variant AxA that lacks two of the three
catalytic metal ligands (Asp114 and Glu116), or a primase-
deficient PrimPol lacking the Zn-finger domain (3). To val-
idate the results obtained in vitro with the different mutants
at the WFYY motif of human PrimPol, we used stretched
DNA fiber analysis to measure fork rate (FR) in functional
complementation assays, downregulating the expression of
endogenous PrimPol and reintroducing the W87G, F88L,
Y89D, Y90D mutant versions. The expression levels of V5-
tagged WT PrimPol and WYFF mutant versions were ap-
proximately similar, and their subcellular distribution in
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Figure 4. Trp87 and Tyr90 residues are essential for PrimPol polymerase activity. (A) Standing-start polymerization by human PrimPol and WFYY mutants
(200 nM) on an undamaged template (X = G; left panel) or on a template containing an 8oxoG lesion (X = 8oxoG; right panel). dNTPs were added in
increasing concentrations (1, 10, 100 M) in the presence of 1 mM MnCl2. (B) Standing-start polymerization assay using 2 nM of a template containing
either a template G (left panel) or an 8oxoG lesion (right panel), and providing 200 nM of either WT PrimPol or F88L, Y89D variants. dNTPs were
individually added at a concentration of 1 M. The histogram shows the quantification of the reactions shown in part B, obtained by densitometry of the
bands corresponding to the extended primer. In all cases, the histograms represent the mean ± SEM (standard error of the mean) from three different
experiments. Statistical data analysis for the correct dC insertion opposite dG, and for the two alternative insertions (dA and dC) opposite 8oxodG, was
performed using Student’s t test (ns, not significant > 0.05, *P < 0.05, **P < 0.01 and ***P < 0.001) for each WT/mutant pair.
Table 1. Steady-state kinetic parameters of dGTP insertion by WT PrimPol versus F88L and Y89D variants. Data are means (± standard error) from at
least three independent experiments
Protein Template dNTP Km (M) Km (WT/mutant) kcat (s–1) Cat. eff. (s–1 M–1) Cat. eff. (WT/mutant)
WT dC dGTP 0.97 ± 0.08 1 (3 ± 0.003) x 10–3 3 × 10–3 1
F88L dC dGTP 4.37 ± 0.96 4.5 (2 ± 0.006) x 10–3 4 × 10–4 7.5
Y89D dC dGTP 1.45 ± 0.47 1.5 (1 ± 0.005) x 10–3 7 × 10–4 4.3
good agreement with in vitro data, W87G and Y90D mu-
tants lacking primase and polymerase activity were unable
to reverse the effect of PrimPol loss on FR, W87G being
as inefficient as the AxA catalytically-dead mutant (Figure
6A). Conversely, F88L and Y89D variants rescued FR at
the same level as the reintroduction of WT PrimPol, sug-
gesting that their remaining activity is sufficient to sustain
the normal range of FR under unperturbed conditions (Fig-
ure 6A).
Under DNA replication stress (RS) induced by UV or
HU treatment, RNAi-mediated downregulation of endoge-
nous PrimPol levels produces a significant drop in the frac-
tion of restarted forks, which can be complemented only
by a primase-proficient PrimPol (3). During UV treatment,
RS is caused by the formation of pyrimidine dimers among
other lesions created that increase the frequency of fork
stalling. In the case of HU, RS is produced by a decrease in
the available pools of dNTPs. Again, in agreement with the
in vitro data, when the two most conserved residues of the
WFYY motif (Trp87 and Tyr90) are mutated, the capacity
of PrimPol to sustain repriming and rescue of stalled forks
in vivo is lost (Figure 6C). Again, the Y89D variant was as
efficient as WT PrimPol to rescue stalled forks under both
treatments (UV, HU), which correlates well with its WT-like
primase and TLS activities (Figure 6B, C). Interestingly, the
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Figure 5. F88L variant is defective in TLS reactions on UV-damaged DNA. (A) DNA polymerization assay on a control (undamaged) template. (B) DNA
polymerization assay on a template containing a 6-4 PP lesion where + 8 and + 11 bands are produced after primer realignment (3,16), as indicated in the
schematics. The reactions contain 100 M dNTPs, 2 nM DNA, 1 mM MnCl2, and 200 nM of either WT or F88L, Y89D variants. The selected images are
representative of at least three different experiments.
cue the stalled forks after UV-damage or upon HU treat-
ment (Figure 6C), probably due to its reduced 3′ nucleotide
binding, that affects both its primase activity and its TLS
abilities to avoid/skip UV-lesions as 6,4 PP, as previously
shown.
These experiments demonstrate that the WFYY motif of
human PrimPol is relevant for its in vivo function, and show
an excellent agreement with the results obtained in vitro. Of
note, the data shown here do not indicate any loss of func-
tionality for mutant Y89D in human cells, which is in con-
trast with previous results (21) and might also questions the
link of this specific mutation with High Myopia (20) and
PEO (22). On the other hand, our analysis of the F88L mu-
tant indicates a reduced enzymatic potential of this human
PrimPol variant for its contribution to minimize DNA repli-
cation stress.
Structural basis for the defective 3′nucleotide binding associ-
ated to mutations at the WFYY motif
The crystal structure of human PrimPol in complex with
both DNA and incoming 3′dNTP (PDBid: 5L2X; 19; see
Figure 7A) provides valuable information to infer the role
of the WFYY motif. As shown in Figure 7B, Trp87 can es-
tablish Van der Waals interactions with Phe327 (located in
-helix 6; depicted in green), whose relevance is supported
by the invariant presence of this residue in PrimPols from
animals and plants; a nearby aromatic residue in human
PrimPol, Tyr324, can also establish complementary interac-
tions with Trp87, and its neighbor residue Glu323 makes a
polar interaction with Tyr293 (located at the loop after ß-
strand 11; depicted in brown). Strikingly, Tyr293 and Ser295
directly interact with Tyr90 of the WFYY motif. More-
over, these two residues Trp87 and Tyr90 also make mutual
contacts.
In light of the results obtained by mutational analysis
of WFYY motif, which outlined the importance of Trp87
and Tyr90 in binding the incoming 3′-site nucleotide, our hy-
pothesis is that the network of interactions maintained by
these two residues, that would be lost by W87G and Y90D
mutations, is crucial to induce a large torsion in ß-strand 11
(indicated with an arrow in Figure 7B) that keeps the appro-
priate orientation of the catalytic Arg291 and perhaps that
of other residues as Lys297 and Lys300, to allow their stabi-
lizing interactions with the 3′-incoming nucleotide via the
3′-OH group and the triphosphate moiety (see Figure 7B,
and the scheme in Figure 7C). Moreover, a precise orien-
tation of Arg291 is also needed to allow its interaction with
the invariant Ser167, invariant at motif B in AEPs (Figure
7B, C).
The crystal structure (19) also shows that Phe88, not
strictly conserved at the WFYY motif, interacts with Glu85
via its main chain (Figure 7B,C). Glu85 directly contacts
Trp42, and an alteration of this interaction due to the F88L
mutation could modify the orientation of residues His46,
Arg47 and Gln48 that are crucial in the positioning of the
templating base (shown in red in Figure 7B). The F88L mu-
tation did not affect the overall interaction with the ssDNA
template (Figure 3A), and had a WT-like CD spectrum
(Figure 3B), suggesting unaltered overall protein structure.
Still, the orientation of the templating base could be af-
fected, explaining the reduced formation of the pre-ternary
complex (Figure 3B,C) and the lower affinity for the in-
coming nucleotide during polymerization (Table 1). Alter-
natively, the lack of the aromatic ring in the F88L muta-
tion could alter the interaction network involving Trp87 and
Tyr90, thus partially affecting the capacity to bind the 3′-site
incoming nucleotide. Interestingly, the reduced activity of
the F88L variant was able to sustain a normal fork rate but
failed to restart stalled replication forks after stress, a differ-
ence that could be valuable for prognosis of those cancers
characterized by high levels of replication stress (33).
The crystal structure of human PrimPol also shows that
Tyr89, moderately conserved at the WFYY motif, can es-
tablish Van der Waals interactions with the close residue
Phe86 (via its main chain and phenyl ring) and also with
Trp42 (via their aromatic moieties). Phe86 also interacts with
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Figure 6. The WFYY motif of human PrimPol is crucial to maintain an optimal replication fork rate and to reprime stalled forks after replicative stress. (A)
PrimPol Trp87 and Tyr90 are required to maintain the replication fork rate in S-phase. The schematics outline the workflow of the experiment (see Materials
and Methods). Fork rate (FR) values were calculated from stretched fibers corresponding to unperturbed DNA replication of HeLa-shPrimPol cells with or
without doxycycline treatment. Microscopy images show representative pictures of the DNA fibers with (–Dox) and without (+Dox) endogenous PrimPol
(scale bar 10 m), performed as described (3) When indicated, plasmids encoding V5-tagged WT, AxA or WFYY mutants were transfected into HeLa-
shPrimPol cells (N = 2), to evaluate their capacity to complement the absence of the endogenous PrimPol. N forks > 300; n.s. = not significant, ***P < 0.001
(Mann–Whitney test). (B, C) Trp87, Phe88 and Tyr90 residues are necessary to reprime UV-stalled (B) and HU-stalled (C) forks. The schematics outline the
workflow of the experiments (see Materials and Methods). Histograms show the quantification of the percentage of fork restart upon UV-irradiation (B)
or HU treatment (C) in HeLa-shPrimPol cells with or without Dox treatment (performed as described in reference 3). When indicated, plasmids encoding
V5-tagged WT, AxA or different point WFYY mutants were transfected. (N = 2) to evaluate their capacity to complement the reduction of rescued forks
(N structures = 500) caused by the absence of the endogenous PrimPol (N = 2). One-way ANOVA and Bonferroni post-test were applied, *** P < 0.0001,
n.s.: not significant.
acts with the aromatic ring of Trp42. Modeling of the Y89D
mutation in the 3D-structure showed that the Asp residue
can make similar interactions with Phe86 and Trp42, and a
polar contact with Tyr90 via its main chain. Therefore, the
Y89D mutation appears to be structurally conservative, ex-
plaining the moderate effect of this alteration on PrimPol
in vitro activities and the absence of an effect on the tested
PrimPol in vivo activities. Interestingly, a single mutation of
Tyr89 to Arg (Y89R), a change that is invariantly present
in the WxRY motif of plant PrimPols (see Supplementary
Figure S1), enhanced the capacity of human PrimPol as an
efficient RNA-dependent-DNA primase/polymerase (34).
Strikingly, this randomly selected mutation (Y89R) dis-
played an increased stabilization of the preternary complex
(protein:template DNA:incoming nucleotide), the specific
step preceding dimer formation.
Overall, the 3D structural model allows to infer that
the WxxY motif conserved in eukaryotic PrimPols has
an indirect but fundamental role in stabilizing the 3′-
incoming dNTP, in order to form a pre-ternary complex
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Figure 7. Structural basis for the defective 3′-nucleotide binding associated to mutations at the WFYY motif. (A) Ribbon representation of the quaternary
complex of HsPrimPol:DNA:dATP (PDB id: 5L2X; 19), depicting the interaction of PrimPol (green) with DNA (primer strand is colored cyan, and
templating strand in white) and dATP (yellow). Residues of motifs A and C acting as metal ligands (Asp114, Glu116, Asp280) are indicated in red, and the
invariant histidine (H169) of motif B is indicated in purple. The amino acid segment spanning residues 279 to 303 is colored brown, and the small alpha
helix (residues 84–90), containing the WFYY motif, is colored in pink. (B) Enlarged view of the region boxed in A, showing specific residues interacting
with the 3′-incoming nucleotide (in yellow), and with the templating DNA (in white/red); moreover, other amino acid residues (mostly aromatic) forming
an interaction network with residues of the WFYY motif are also highlighted (see text for details). The arrow indicates the torsion at the ß-strand 11(in
brown), likely maintained by a network of interactions involving the WxxY motif. (C) Schematics of the different interactions affecting the template and
incoming 3′-deoxynucleotide, involving the WFYY motif and other segments of the PrimPol 3D-structure.
Mutation Y89D in human PrimPol is not supportive of a cor-
relation with High Myopia
Despite the importance of PrimPol in damage tolerance
during DNA replication, its association with human dis-
ease remains largely unknown. In 2013, a study of exome se-
quencing described that a point mutation in PrimPol, Y89D
(located at the WFYY motif studied here), correlated with
the development of High Myopia in human patients (20).
The following year, another study claimed that the Y89D
mutation negatively affected the DNA binding capacity and
enzymatic activities of PrimPol (21); this report also de-
scribed that the Y89D mutation induced structural changes
in PrimPol and therefore, its lower activity in vitro and in
vivo was correlated with an inefficient protein folding. In
contrast, our structure-function analysis shows that the pre-
dicted pathological mutation Y89D does only mildly affect
the activity of PrimPol in vitro. To reinforce our conclusions,
we tested a Y89D protein obtained with a different expres-
sion and purification method (see Supplementary Figure
S3). This alternative Y89D mutant protein again showed a
near to WT PrimPol-like activity in DNA polymerase as-
says, in spite of using different assay conditions, including
a different DNA substrate and the less efficient Mg2+ ac-
tivating ions (Supplementary Figure S3A). Moreover, the
Y89D mutant and WT PrimPol were similarly stimulated by
PolDIP2 (Supplementary Figure S3B), an accessory protein
described to be a PrimPol partner (35), and equally efficient
to cooperate with Pol for coupling primer synthesis and
processive elongation (Supplementary Figure S3C). The in
vitro discrepancies between our study and that of Keen et al.
(21) could be explained by differences in protein expression
and purification. In contrast with the results reported (21),
the WT and Y89D PrimPol mutant proteins used in our
study had very similar CD spectra (Figure 3B), suggesting
unaltered overall protein structure of the mutant. This re-
sult further supports the hypothesis that the Y89D muta-
tion only has a minor effect on the catalytic activities of
PrimPol.
Furthermore, our in vivo results show that Y89D is per-
fectly capable of substituting for endogenous PrimPol in an
unchallenged S phase and during the response to UV irra-
diation or dNTPs attrition. In this case, the in vivo discrep-
ancies could be related to the fact that Keen et al. (21) re-
constituted the loss of endogenous PrimPol in avian DT40
cells with human PrimPol, a heterologous system that may
not be suitable to validate the activity of human PrimPol
mutations. More importantly, a subsequent genetic study
has revealed that Y89D is a common polymorphic Prim-
Pol variant that appears in the control population with sim-
ilar frequency than in patients with High Myopia (23). This
genetic study combined with our functional analysis of the
Y89D mutation do not support the conclusions of Zhou
et al. (20) and Keen et al. (21), and the more recent pro-
posal that the Y89D polymorphism could be also associ-
ated to PEO (22). Consequently, we suggest that several
annotations that the Y89D mutation of human PrimPol
is pathogenic and related to High Myopia ought to be re-
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CONCLUDING REMARKS
We have identified a conserved motif (WFYY) in the N-
terminal domain of human PrimPol, whose flanking amino
acids (Trp87 and Tyr90) are invariant in other eukaryotic
and archaeal PrimPols. On the other hand, Phe88 and Trp89
residues were conserved only in PrimPols from vertebrates.
In agreement with their structural conservation, Trp87 and
Tyr90 were shown to be crucial for the stability of the 3′-
incoming nucleotide at human PrimPol active site. Accord-
ingly, W87G and Y90D mutants destroyed PrimPol abilities
as a primase and TLS polymerase, and also the capacity to
re-start stalled replication forks challenged by UV damage
or dNTP deprivation.
Interestingly, the human PrimPol variant F88L, located
at the WFYY motif, could substitute for the function of
endogenous PrimPol in an unperturbed S-phase, but not
when the forks were stalled by UV or HU. As the ability to
restart forks resides mainly in the primase activity of Prim-
Pol (3,5,14,15,32,36), these results suggest that the reduced
primase activity of the F88L variant is capable of dealing
with endogenous fork stalling, but fails to do so when DNA
replication is extensively challenged with UV irradiation or
dNTP attrition. Finally, human PrimPol mutant Y89D did
not significantly affect the PrimPol in vivo activities tested,
questioning the reported Y89D correlation with High My-
opia (20,21) and PEO (22).
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5. Torregrosa-Muñumer,R., Forslund,J.M.E., Goffart,S., Pfeiffer,A.,
Stojkovic,G., Carvalho,G., Al-Furoukh,N., Blanco,L., Wanrooij,S.
and Pohjoismaki,J.L.O. (2017) PrimPol is required for replication
reinitiation after mtDNA damage. Proc. Natl. Acad. Sci. U.S.A., 114,
11398–11403.
6. Lipps,G., Rother,S., Hart,C. and Krauss,G. (2003) A novel type of
replicative enzyme harbouring ATPase, primase and DNA
polymerase activity. EMBO J., 22, 2516–2525.
7. Sanchez-Berrondo,J., Mesa,P., Ibarra,A., Martinez-Jimenez,M.I.,
Blanco,L., Mendez,J., Boskovic,J. and Montoya,G. (2012) Molecular
architecture of a multifunctional MCM complex. Nucleic Acids Res.,
40, 1366–1380.
8. Bocquier,A.A., Liu,l., Cann,I.K., Komori,K., Kohda,D. and
Ishino,Y. (2001) Archaeal primase: bridging the gap between RNA
and DNA polymerases. Curr. Biol. 11, 452–456.
9. Keen,B.A., Jozwiakowski,S.K., Bailey,L.J., Bianchi,J. and
Doherty,A.J. (2014) Molecular dissection of the domain architecture
and catalytic activities of human PrimPol. Nucleic Acids Res., 42,
5830–5845.
10. Iyer,L.M., Koonin,E.V., Leipe,D.D. and Aravind,L. (2005) Origin
and evolution of the archaeo-eukaryotic primase superfamily and
related palm-domain proteins: structural insights and new members.
Nucleic Acids Res., 33, 3875–3896.
11. Martinez-Jimenez,M.I., Calvo,P.A., Garcia-Gomez,S.,
Guerra-Gonzalez,S. and Blanco,L. (2018) The Zn-finger domain of
human PrimPol is required to stabilize the initiating nucleotide during
DNA priming. Nucleic Acids Res., 46, 4138–4151.
12. Blanco,L., Calvo,P.A., Diaz-Talavera,A., Carvalho,G., Calero,N.,
Martı́nez-Carrón,A., Velázquez-Ruiz,C., Villadangos,S., Guerra,S.
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